Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -144.24% is in line with its 1-year average of -135.77%, near the low end of its 1-year range (-144.24%–-131.74%).
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
-144.24%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mobia Medical, Inc. Common Stock
Market Cap
$304.43M
EBITDA Margin
-144.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$300.61M
EBITDA Margin
-24933.33%
TTM Avg
-24426.94%
3Y Avg
-19832.71%
5Y Avg
-13250.84%
Market Cap
$316.22M
EBITDA Margin
-285.23%
TTM Avg
-308.13%
3Y Avg
-415.00%
5Y Avg
-335.56%
Market Cap
$321.61M
EBITDA Margin
11.45%
TTM Avg
4.69%
3Y Avg
-3.39%
5Y Avg
-11.89%
Market Cap
$321.93M
EBITDA Margin
-56.12%
TTM Avg
-71.22%
3Y Avg
-76.13%
5Y Avg
-77.81%
Market Cap
$322.39M
EBITDA Margin
-59.31%
TTM Avg
-58.08%
3Y Avg
-69.87%
5Y Avg
-66.91%
Market Cap
$323.73M
EBITDA Margin
-184.07%
TTM Avg
-174.53%
3Y Avg
-153.81%
5Y Avg
-153.81%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $304.43M | -144.24% | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $300.61M | -24933.33% | -24426.94% | -19832.71% | -13250.84% |
| C4 Therapeutics, Inc. (CCCC)vs › | $316.22M | -285.23% | -308.13% | -415.00% | -335.56% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $294.51M | N/A | N/A | N/A | N/A |
| Sanara MedTech Inc. (SMTI)vs › | $321.61M | 11.45% | 4.69% | -3.39% | -11.89% |
| Avita Medical Inc. (RCEL)vs › | $321.93M | -56.12% | -71.22% | -76.13% | -77.81% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $322.39M | -59.31% | -58.08% | -69.87% | -66.91% |
| CapsoVision, Inc. (CV)vs › | $323.73M | -184.07% | -174.53% | -153.81% | -153.81% |
| Cabaletta Bio, Inc. (CABA)vs › | $323.66M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $288.39M | -101.16% | -95.97% | -88.25% | -69.69% |
Gross Margin
81.1%
EBITDA Margin
-144.2%
Operating Margin
-144.7%
Net Margin
-145.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -131.74% |
| 2026-03-31 | -139.81% |
